Immediate Impact

54 standout
Sub-graph 1 of 24

Citing Papers

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
Harnessing innate immune pathways for therapeutic advancement in cancer
2024 Standout
2 intermediate papers

Works of Philipp Mayer being referenced

Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors
2020
Changes in the microarchitecture of the pancreatic cancer stroma are linked to neutrophil-dependent reprogramming of stellate cells and reflected by diffusion-weighted magnetic resonance imaging
2017

Author Peers

Author Last Decade Papers Cites
Philipp Mayer 464 295 234 75 844
Funda Obuz 362 397 212 71 862
Sevastiţa Iordache 500 432 224 48 918
Wenjie Liang 264 272 419 60 849
Nikolaos Kartalis 539 361 345 46 984
K. West 269 254 124 45 942
Chaobin He 515 275 70 60 948
Hyo Won Eun 459 495 180 37 860
Qing Xu 171 177 307 40 672
Takahiro Einama 481 224 71 81 842
Hyung Il Seo 248 629 87 77 953

All Works

Loading papers...

Rankless by CCL
2026